ReviewJournal of clinical medicine2023

The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBD.

Kathryn Demase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.